Drug intelligence / Profile preview

Ashwamed

Development stage: Unknown
Lead developer: Bal Pharma
Administration: Oral

Overview

Ashwamed is a proprietary Ayurvedic medicine manufactured by Balvedics Pharma, the herbal division of Bal Pharma. It is specifically formulated to support male reproductive health and address conditions such as male infertility, sexual dysfunction, premature ejaculation, and erectile dysfunction. The formulation contains a blend of traditional Ayurvedic herbs, including Ashwagandha (Withania somnifera), Krishna musali (Curculigo orchioides), and Kapikacchu (Mucuna pruriens). Ashwamed functions as a spermatogenic and aphrodisiac agent, aimed at improving sperm count and motility, enhancing libido, and reducing performance-related stress and fatigue.

Brand names: Ashwamed
Other names: Ashwamed Capsule

Beyond the preview

Go deeper on Ashwamed.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ashwamed.

Explore the full profile